source
- UK regulator reports rise in drug approvals and steps to regulate AI in healthcareThe Medicines and Healthcare products Regulatory Agency (MHRA) presented its 2025-2026 annual report to Parliament, highlighting a higher number of new drug approvals compared with the previous yea…
- Axiom Biosciences to launch IPO on Hong Kong exchange before Nasdaq co‑listingSan Diego‑based Axiom Biosciences announced plans to go public with a primary listing on the Hong Kong Stock Exchange, followed later by a Nasdaq co‑listing, a structure it says is a first for a U.…